Retinoblastoma Treatment

Retinoblastoma Treatment

Retinoblastoma is a rare eye cancer that usually occurs in young children. Early specialist evaluation is important to protect the child's life and, where possible, preserve the eye and vision.

WhatsApp
India
USD 5,000–20,000BEST SAVINGS
Turkey
USD 8,000–25,000
Thailand
USD 10,000–30,000
UAE
USD 20,000–50,000
USA
USD 50,000–150,000
Germany
USD 25,000–70,00
UK
USD 30,000–80,000
Singapore
USD 25,000–60,000

Need help in choosing the right package for your medical trip?

Chat to our experts now

Your health data is protected with us

Why Choose us?

Value

Focused care

0+

Ophthalmology Doctors

1+

Retinoblastoma Treatment

3+

Hospitals Around the world

100%

Privacy protected

Overview

1. What is Retinoblastoma?

Retinoblastoma is a cancer that develops in the retina, the light-sensitive tissue at the back of the eye.

It may affect:

  • One eye (unilateral retinoblastoma)
  • Both eyes (bilateral retinoblastoma)

Treatment priorities generally focus first on saving the child's life, followed by preserving the eye and vision whenever medically possible.

2. What Are the Common Signs and Symptoms?

Possible signs may include:

  • White reflection or glow in the pupil (leukocoria)
  • Squinting or misaligned eyes
  • Redness or swelling of the eye
  • Reduced vision
  • Eye pain in advanced cases
  • Enlargement of the eye in some cases

A child with suspected retinoblastoma requires urgent assessment by an experienced ocular oncology specialist.

3. How Is Retinoblastoma Diagnosed?

Evaluation may include:

  • Specialist eye examination
  • Examination under anaesthesia (EUA) where required
  • Ocular ultrasound
  • MRI of the eye and brain
  • Assessment of both eyes
  • Genetic evaluation in selected patients
  • Additional staging investigations where appropriate

Biopsy is generally avoided in typical intraocular retinoblastoma because of the potential risk of tumour spread.

4. What Treatment Options Are Available?

Treatment depends on the size, location and extent of the tumour and whether one or both eyes are affected.

Options may include:

  • Systemic chemotherapy
  • Intra-arterial chemotherapy in selected patients
  • Intravitreal chemotherapy for selected disease
  • Laser treatment (photocoagulation)
  • Cryotherapy
  • Plaque brachytherapy in selected cases
  • External beam radiation therapy in selected situations
  • Enucleation (removal of the affected eye) when necessary
  • Treatment for advanced or extraocular disease where required

Treatment is planned by a specialised multidisciplinary team.

5. What Does the Treatment Process Involve?

The general treatment pathway includes:

Specialist ocular examination → MRI and diagnostic assessment → Evaluation of both eyes → Disease classification → Multidisciplinary treatment planning → Personalised treatment → Regular eye examinations and imaging → Response assessment → Long-term follow-up

Repeated examinations under anaesthesia may be required during treatment and surveillance, particularly in young children.

6. How Long Does Retinoblastoma Treatment Take?

The duration depends on the extent of disease and treatment approach.

Typical considerations include:

  • Initial evaluation: may require several days
  • Chemotherapy: may be given over multiple treatment cycles
  • Local eye treatments: may require repeated sessions
  • Follow-up examinations: required regularly for several years
  • Long-term surveillance: important, particularly for children with hereditary retinoblastoma

The treating team provides an individual treatment and follow-up schedule.

7. What Are the Expected Outcomes?

When diagnosed and treated appropriately, retinoblastoma can often be successfully controlled.

Treatment aims may include:

  • Saving the child's life
  • Controlling the cancer
  • Preserving the eye where possible
  • Preserving useful vision where possible
  • Reducing the risk of recurrence or spread
  • Providing long-term surveillance

Outcomes depend on the stage, whether disease is limited to the eye, involvement of one or both eyes and response to treatment.

8. What Are the Risks or Considerations?

Risks and considerations depend on the treatment used and may include:

  • Temporary or permanent reduction in vision
  • Effects of chemotherapy
  • Eye inflammation or damage from local treatment
  • Risk of tumour recurrence
  • Need for removal of an eye in advanced cases
  • Long-term monitoring for hereditary forms of retinoblastoma
  • Risk of additional cancers in some patients with hereditary retinoblastoma

The treatment team discusses the expected benefits and risks for the individual child.

9. Why Consider Retinoblastoma Treatment in India?

India has specialised centres offering:

  • Paediatric ophthalmology and ocular oncology expertise
  • Advanced eye imaging and MRI
  • Chemotherapy and specialised local treatments
  • Multidisciplinary paediatric cancer care
  • Paediatric anaesthesia support
  • Eye-preservation treatment where medically appropriate
  • Long-term follow-up and rehabilitation support

10. How Can Medavelle Help and What Should the Patient Do Next?

Medavelle can assist with:

Medical-record review → Ocular oncology specialist coordination → Hospital selection → Diagnosis and staging review → Treatment planning → Cost estimation → International patient arrangements.

Next step: Share ophthalmology & MRI reports → Ocular oncology evaluation → Assessment of both eyes and disease extent → Personalised treatment planning → Appropriate treatment → Regular response assessment → Long-term follow-up.

Top Ophthalmology Hospitals

World-class healthcare facilities specializing in Retinoblastoma Treatment with state-of-the-art technology

Expert Doctors for Retinoblastoma Treatment

Board-certified specialists with experience in ophthalmology treatment planning

Doctor profiles for this category will be updated soon.

FAQs

Many children with retinoblastoma can be successfully treated, particularly when the disease is diagnosed early and managed by a specialised team. The outcome depends on the extent and spread of the cancer.